Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis
Eric Omar Then et al.
WORLD JOURNAL OF ONCOLOGY (2020)
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study
Melina Arnold et al.
LANCET ONCOLOGY (2019)
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer
Amanda O. Salzwedel et al.
Oncotarget (2018)
Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
Christopher J. LaRocca et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Tumor xenograft animal models for esophageal squamous cell carcinoma
Nikki P. Lee et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
Mizuho Sato-Dahlman et al.
ONCOTARGET (2017)
Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas
Christopher J. LaRocca et al.
ORAL ONCOLOGY (2016)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer
Christopher J. LaRocca et al.
SURGERY (2015)
Recent developments in esophageal adenocarcinoma
Jesper Lagergren et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Infectivity-selective Oncolytic Adenovirus Developed by High-throughput Screening of Adenovirus-formatted Library
Yoshiaki Miura et al.
MOLECULAR THERAPY (2013)
Multidisciplinary Management of Esophageal Cancer
Charles R. Mulligan
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2013)
Generation of a novel, cyclooxygenase-2-targeted, interferon-expressing, conditionally replicative adenovirus for pancreatic cancer therapy
Leonard Armstrong et al.
AMERICAN JOURNAL OF SURGERY (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Delivery of interferon alpha using a novel Cox2-controlled adenovirus for pancreatic cancer therapy
Leonard Armstrong et al.
SURGERY (2012)
In vivo bioimaging tracks conditionally replicative adenoviral replication and provides an early indication of viral antitumor efficacy
Julia Davydova et al.
CANCER SCIENCE (2010)
Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia
M. Anders et al.
CANCER GENE THERAPY (2009)
Interferon-α and cancer:: Mechanisms of action and new perspectives of clinical use
Maria Ferrantini et al.
BIOCHIMIE (2007)
Local interferon-α gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster
Hidehiko Hara et al.
CANCER SCIENCE (2007)
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
H Pohl et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity
TO Kirby et al.
CLINICAL CANCER RESEARCH (2004)
Infectivity-enhanced cyclooxygenase-2-based conditionally replicative adenoviruses for esophageal adenocarcinoma treatment
J Davydova et al.
CANCER RESEARCH (2004)
Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer
M Yamamoto et al.
GASTROENTEROLOGY (2003)
Overexpression of the ADP (E3-11.6K) protein increases cell lysis and spread of adenovirus
K Doronin et al.
VIROLOGY (2003)
Potential of interferon-alpha in solid tumours Part 1
M Decatris et al.
BIODRUGS (2002)
Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors
DAM Heideman et al.
CANCER GENE THERAPY (2001)
Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein
K Doronin et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
